PETCO2 at AT Index Calculator
Measurement and interpretation
Enter PETCO₂ measured at the anaerobic/ventilatory threshold during CPET.
This is a prognostic marker, not a stand-alone diagnosis or treatment recommendation. Interpret alongside symptoms, examination, the full CPET profile, and the clinical setting.
Clinical explanation
End-tidal carbon dioxide partial pressure (PETCO₂) measured at the ventilatory threshold reflects the interaction between pulmonary perfusion, ventilation, and carbon dioxide production during exercise. In heart failure cohorts, a lower value at threshold has been associated with impaired exercise haemodynamics and adverse cardiac outcomes.
Evidence-based threshold
A study of 130 patients with compensated heart failure reported an optimal PETCO₂-at-ventilatory-threshold cut point of 36.1 mmHg for separating higher- and lower-risk groups. In that study, values at or below the cut point identified the higher-risk group; this is a cohort-derived prognostic threshold, not a universal normal range.
| PETCO₂ at VT | Study-based grouping | Meaning |
|---|---|---|
| ≤36.1 mmHg | Higher risk group | Associated with greater risk of cardiac-related events in the cited compensated-HF cohort. |
| >36.1 mmHg | Lower risk group | Lower-risk group relative to the study cut point; does not exclude disease or future events. |
Important limitations
- The cut point was derived in a specific cohort of patients with compensated heart failure and should not be generalized uncritically to all CPET populations.
- Threshold identification, protocol, respiratory pattern, pulmonary vascular disease, and other clinical factors may affect interpretation.
- Use PETCO₂ alongside established CPET variables, including peak VO₂ and the VE/VCO₂ slope, rather than in isolation.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.